Company Filing History:
Years Active: 2003-2008
Title: The Innovations of Brandon Wainwright
Introduction
Brandon Wainwright is an accomplished inventor based in Bardon, Australia. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. With a total of 2 patents to his name, Wainwright's work focuses on tumor suppressor genes and their implications in basal cell carcinoma.
Latest Patents
Wainwright's latest patents include groundbreaking inventions related to basal cell carcinoma. The first patent addresses the tumor suppressor gene inactivation, which is a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. This invention highlights the NBCCS gene, a homologue of the patched (ptc) gene. His second patent also focuses on the basal cell carcinoma tumor suppressor gene, reiterating the importance of this gene in cancer research and treatment.
Career Highlights
Brandon Wainwright is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been pivotal in advancing our understanding of cancer biology and developing potential therapeutic strategies.
Collaborations
Wainwright has collaborated with notable colleagues, including Michael C. Dean and Heidi Eve Hahn. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Brandon Wainwright's innovative work in the field of cancer research exemplifies the impact of dedicated inventors on medical science. His patents on tumor suppressor genes are crucial for understanding and potentially treating basal cell carcinoma.